Ausgabe 6/2010
Inhalt (23 Artikel)
Determining the role of radiotherapy in the adjuvant management of gastric cancer: an ocean apart
Benjamin W. Corn, Ravit Geva
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Aristotelis Bamias, M. Karina, P. Papakostas, I. Kostopoulos, M. Bobos, G. Vourli, E. Samantas, Ch. Christodoulou, G. Pentheroudakis, D. Pectasides, M. A. Dimopoulos, G. Fountzilas
Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
Matthew K. Wong, Alvis I. Lo, Bing Lam, W. K. Lam, Mary S. Ip, James C. Ho
Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis
Seong Tae Park, Jeong Won Jang, Gi Dae Kim, Joung Ah Park, Wonhee Hur, Hyun Young Woo, Jin Dong Kim, Jeong Hyun Kwon, Chan Ran Yoo, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
LLL-3, a STAT3 inhibitor, represses BCR-ABL-positive cell proliferation, activates apoptosis and improves the effects of Imatinib mesylate
Andre Luiz Mencalha, B. Du Rocher, D. Salles, R. Binato, E. Abdelhay
Differential roles of Trk and p75 neurotrophin receptors in tumorigenesis and chemoresistance ex vivo and in vivo
Muriel Bassili, Elena Birman, Nina F. Schor, H. Uri Saragovi
Pharmacokinetics of carboplatin and etoposide in infant neuroblastoma patients
Gareth J. Veal, Michael Cole, Julie Errington, Andrew D. J. Pearson, Mary Gerrard, Gavin Whyman, Caroline Ellershaw, Alan V. Boddy
The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines
Allison Pledgie-Tracy, Madhavi Billam, Amy Hacker, Michele D. Sobolewski, Patrick M. Woster, Zhe Zhang, Robert A. Casero, Nancy E. Davidson
In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines
Holger Peter Behrsing, Michael J. Furniss, Kristine A. Robillard, Joseph E. Tomaszewski, Ralph E. Parchment
Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study
Wasaburo Koizumi, Toshikazu Akiya, Atsushi Sato, Toshikazu Sakuyama, Eisaku Sasaki, Takashi Tomidokoro, Tsutomu Hamada, Mototsugu Fujimori, Yoshinori Kikuchi, Ken Shimada, Tetsuya Mine, Kensei Yamaguchi, Tsuneo Sasaki, Minoru Kurihara
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Takashi Sasaki, Hiroyuki Isayama, Yousuke Nakai, Yukiko Ito, Hirofumi Kogure, Osamu Togawa, Nobuo Toda, Ichiro Yasuda, Osamu Hasebe, Iruru Maetani, Naoki Sasahira, Kenji Hirano, Takeshi Tsujino, Minoru Tada, Masao Omata
Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys
Izet M. Kapetanovic, Miguel Muzzio, Shu-Chieh Hu, James A. Crowell, Roger A. Rajewski, John L. Haslam, Ling Jong, David L. McCormick
Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats
Tomoko Maeda, Yuko Miyazono, Kousei Ito, Kazuma Hamada, Shuichi Sekine, Toshiharu Horie
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias
Robin E. Norris, Peter C. Adamson
PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-κB
H. Bark, Cheol-Hee Choi
Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma: a case series
Liliana Montella, Raffaele Addeo, Giovannella Palmieri, Michele Caraglia, Gregorio Cennamo, Bruno Vincenzi, Rosario Guarrasi, Rosanna Mamone, Vincenzo Faiola, Nicola Frega, Elena Capasso, Luigi Maiorino, Davide Leopardo, Carmine Pizza, Vincenzo Montesarchio, Salvatore Del Prete
Pharmacokinetics and distribution of SN 28049, a novel DNA binding anticancer agent, in mice
Pradeep B. Lukka, James W. Paxton, Philip Kestell, Bruce C. Baguley
Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse
Iris-Susanne Horn, Gunnar Wichmann, Christian Mozet, Andreas Dietz, Ralph Dollner, Katrin Tschöp, Andreas Boehm
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Anne von Heideman, Åke Berglund, Rolf Larsson, Peter Nygren
Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children
Sharon Conroy, Martin Garnett, Michael Vloeberghs, Richard Grundy, Ian Craven, David Walker
Novel d-erythro N-octanoyl sphingosine analogs as chemo- and endocrine-resistant breast cancer therapeutics
James W. Antoon, Jiawang Liu, Adharsh P. Ponnapakkam, Matthew M. Gestaut, Maryam Foroozesh, Barbara S. Beckman
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer
Orazio Caffo, Stefania Fallani, Elena Marangon, Stefania Nobili, Maria Iris Cassetta, Viviana Murgia, Federica Sala, Andrea Novelli, Enrico Mini, Massimo Zucchetti, Enzo Galligioni
Population pharmacokinetic study of a test dose oral busulfan in Japanese adult patients undergoing hematopoietic stem cell transplantation
Yasushi Takamatsu, Noriaki Sasaki, Kentaro Ogata, Eiji Yukawa, Shiro Jimi, Shuuji Hara, Kazuo Tamura